FDA-NJPQCA Conference

Our 2024 NJPQCA-FDA Conference, Navigating Global Quality Challenges, was a huge success! Thank you to all speakers, panelists, and participants!  We hope to hold another NJPQCA-FDA Conference in 2027.

Those who joined us…

  • Gained the most current perspective on FDA expectations.

  • Listened and learned from the senior leaders and SMEs from FDA, Bristol Myers Squibb, Johnson & Johnson, Compliance Insight Inc., Syner-G BioPharma, and SciLucent Inc. on compliance issues, continuous manufacturing and release, counterfeiting, outsourcing QA, and overseas inspections.

  • Engaged in a Panel Discussion on Global Quality Agreements with industry SMEs from Merck, Ricola, Pharmaloz Manufacturing Inc., and Piramal Pharma Ltd.

Comments from our 2023 Conference participants:

The Panel Discussion on vendor quality was fabulous…loaded with information!

FDA’s retrospective and prospective presentations were most helpful

All topics were relevant, with great content

Learned from each presentation

Time and pace of presentations were strong, everything was excellent

Good format

Nice location

Keep up the good work for the industry!